Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens

European Journal of Pharmacology

Volumn 747, Issue , 2015, Pages 174-180

  Anugraha, Gandhirajan ^a   Madhumathi, Jayaprakasam ^a   Jeya Prita, Parasurama Jawaharlal ^a   Kaliraj, Perumal ^a  

^a ANNA UNIVERSITY   (India)

Author keywords

Adjuvants; Controlled release delivery system; Immune response; Lymphatic filariasis; Microsphere; Poly l lactide

Indexed keywords

ALUMINUM POTASSIUM SULFATE; FILARIAL EPITOPE PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; INTERLEUKIN 4; INTERLEUKIN 5; POLYLACTIDE; THIOREDOXIN VENOM ALLERGEN HOMOLOG VACCINE; UNCLASSIFIED DRUG; VACCINE; ANTIGEN; CYTOKINE; DELAYED RELEASE FORMULATION; DRUG CARRIER; EPITOPE; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; MICROSPHERE; POLYESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG DELIVERY SYSTEM; EMULSION; HUMORAL IMMUNITY; IN VITRO STUDY; MICROENCAPSULATION; MOUSE; NONHUMAN; PROTEIN STABILITY; ADSORPTION; ANIMAL; CHEMISTRY; CYTOLOGY; DELAYED RELEASE FORMULATION; ELEPHANTIASIS, FILARIAL; IMMUNOLOGY; METABOLISM; SPLEEN;

ADJUVANTS, IMMUNOLOGIC; ADSORPTION; ANIMALS; ANTIGENS; CELL PROLIFERATION; CYTOKINES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; ELEPHANTIASIS, FILARIAL; EPITOPES; MICE; MICROSPHERES; POLYESTERS; RECOMBINANT FUSION PROTEINS; SPLEEN; VACCINES;

EID: 84920083010     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.12.004     Document Type: Article

References (41)

1. D.R. Absolom, W. Zingg, and A.W. Neumann Protein adsorption to polymer particles: role of surface properties J. Biomed. Mater. Res. 21 1987 161 171
2. Y. Akiyama, M.D. Lubeck, Z. Steplewski, and H. Koprowski Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon Cancer Res. 44 1984 5127 5131
3. S.B. Anand, K.N. Kodumudi, M.V. Reddy, and P. Kaliraj A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds J. Helminthol. 85 2011 442 452
4. S.B. Anand, V. Murugan, P.R. Prabhu, V. Anandharaman, M.V. Reddy, and P. Kaliraj Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice Acta Trop. 107 2008 106 112
5. G. Anugraha, P.J. Jeyaprita, J. Madhumathi, T. Sheeba, and P. Kaliraj Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis Acta Parasitol. 58 2013 468 477
6. S. Babu, L.M. Ganley, T.R. Klei, L.D. Shultz, and T.V. Rajan Role of gamma interferon and interleukin-4 in host defense against the human filarial parasite Brugia malayi Infect. Immun. 68 2000 3034 3035
7. S. Babu, L.D. Shultz, T.R. Klei, and T.V. Rajan Immunity in experimental murine filariasis: roles of T and B cells revisited Infect. Immun. 67 1999 3166 3167
8. M.J. Bockarie, and R.M. Deb Elimination of lymphatic filariasis: do we have the drugs to complete the job? Curr. Opin. Infect. Dis 23 2010 617 620
9. G. Boehm, M. Peyre, D. Sesardic, R.J. Huskisson, F. Mawas, A. Douglas, D. Xing, H.P. Merkle, B. Gander, and P. Johansen On technological and immunological benefits of multivalent single-injection microsphere vaccines Pharm. Res. 19 2002 1330 1336
10. A.G. Coombes, E.C. Lavelle, and S.S. Davis Biodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed protein Vaccine 17 1999 2410 2422
11. A.G. Coombes, E.C. Lavelle, P.G. Jenkins, and S.S. Davis Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen Vaccine 14 1996 1429 1438
12. G. Dakshinamoorthy, A.K. Samykutty, G. Munirathinam, M.V. Reddy, and R. Kalyanasundaram Multivalent fusion protein vaccine for lymphatic filariasis Vaccine 31 2013 1616 1622
13. W.F. Gregory, M.L. Blaxter, and R.M. Maizels Differentially expressed, abundant trans-spliced cDNAs from larval Brugia malayi Mol. Biochem. Parasitol. 87 1997 85 95
14. R.K. Gupta, M. Singh, and D.T. O'Hagan Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines Adv. Drug Deliv. Rev. 32 1998 225 246
15. J.O. Gyapong, V. Kumaraswami, G. Biswas, and E.A. Ottesen Treatment strategies underpinning the global programme to eliminate lymphatic filariasis Expert Opin. Pharmacother. 6 2005 179 200
16. A. Hoerauf, K. Pfarr, S. Mand, A.Y. Debrah, and S. Specht Filariasis in Africa - treatment challenges and prospects Clin. Microbiol. Infect. 17 2011 977 985
17. E. Horisawa, K. Kubota, I. Tuboi, K. Sato, H. Yamamoto, H. Takeuchi, and Y. Kawashima Size-dependency of dl-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium Pharm. Res. 19 2002 132 139
18. D.W. Howie, B. Manthey, S. Hay, and B. Vernon-Roberts The synovial response to intraarticular injection in rats of polyethylene wear particles Clin. Orthop. Relat. Res 1993 352 357
19. D.H. Jones Microencapsulation of vaccine antigens Methods Mol. Med. 87 2003 211 222
20. Y.K. Katare, T. Muthukumaran, and A.K. Panda Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles Int. J. Pharm. 301 2005 149 160
21. A.M. Lange, W. Yutanawiboonchai, P. Scott, and D. Abraham IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice J. Immunol. 153 1994 205 211
22. E.C. Lavelle, M.K. Yeh, A.G. Coombes, and S.S. Davis The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol Vaccine 17 1999 512 529
23. R.A. Lawrence Immunity to filarial nematodes Vet. Parasitol. 100 2001 33 44
24. J. Madhumathi, D. Pradiba, P.R. Prince, P.J. Jeyaprita, D.N. Rao, and P. Kaliraj Crucial epitopes of Wuchereria bancrofti abundant larval transcript recognized in natural infection Eur. J. Clin. Microbiol. Infect. Dis. 29 2010 1481 1486
25. J. Madhumathi, P.R. Prince, G. Anugraha, P. Kiran, D.N. Rao, M.V. Reddy, and P. Kaliraj Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis Vaccine 28 2010 5038 5048
26. J. Madhumathi, P.R. Prince, D.N. Rao, and P. Kaliraj Dominant T-cell epitopes of filarial BmALT-2 and their cytokine profile in BALB/c mice Parasite Immunol. 32 2010 760 763
27. R.M. Maizels, and M. Yazdanbakhsh Immune regulation by helminth parasites: cellular and molecular mechanisms Nat. Rev. Immunol. 3 2003 733 744
28. N. Petrovsky, and J.C. Aguilar Vaccine adjuvants: current state and future trends Immunol. Cell Biol. 82 2004 488 496
29. M. Peyre, R. Audran, F. Estevez, G. Corradin, B. Gander, D. Sesardic, and P. Johansen Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions J. Controlled Release 99 2004 345 355
30. P.R. Prince, J. Madhumathi, G. Anugraha, P.J. Jeyaprita, M.V. Reddy, and P. Kaliraj Tandem antioxidant enzymes confer synergistic protective responses in experimental filariasis J. Helminthol 2013 1 9
31. V. Saini, S.K. Verma, M.K. Sahoo, D.V. Kohli, and P.K. Murthy Sufficiency of a single administration of filarial antigens adsorbed on polymeric lamellar substrate particles of poly (l-lactide) for immunization Int. J. Pharm. 420 2011 101 110
32. C.S. Schmidt, W.J. Morrow, and N.A. Sheikh Smart adjuvants Expert Rev. Vaccines 6 2007 391 400
33. S. Sharmila, I. Christiana, P. Kiran, M.V. Reddy, and P. Kaliraj The adjuvant-free immunoprotection of recombinant filarial protein Abundant Larval Transcript-2 (ALT-2) in Mastomys coucha and the immunoprophylactic importance of its putative signal sequence Exp. Parasitol. 129 2011 247 253
34. L. Shi, M.J. Caulfield, R.T. Chern, R.A. Wilson, G. Sanyal, and D.B. Volkin Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres J. Pharm. Sci. 91 2002 1019 1035
35. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1985 76 85
36. M.J. Taylor, A. Hoerauf, and M. Bockarie Lymphatic filariasis and onchocerciasis Lancet 376 2010 1175 1185
37. S. Thirugnanam, P. Pandiaraja, K. Ramaswamy, V. Murugan, M. Gnanasekar, K. Nandakumar, M.V. Reddy, and P. Kaliraj Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model Exp. Parasitol. 116 2007 483 491
38. U. Vanam, V. Pandey, P.R. Prabhu, G. Dakshinamurthy, M.V. Reddy, and P. Kaliraj Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis Am. J. Trop. Med. Hyg. 80 2009 319 324
39. U. Vanam, P.R. Prabhu, V. Pandey, G. Dakshinamurthy, M.V. Reddy, and K. Perumal Immune responses generated by intramuscular DNA immunization of Brugia malayi transglutaminase (BmTGA) in mice Parasitology 136 2009 887 894
40. A.L. Vincent, W.A. Sodeman, and A. Winters Development of Brugia pahangi in normal and nude mice J. Parasitol. 66 1980 448
41. C. Witschi, and E. Doelker Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing J. Controlled Release 51 1998 327 341